Cargando…
Genomic prediction of relapse in recipients of allogeneic haematopoietic stem cell transplantation
Allogeneic haematopoietic stem cell transplantation currently represents the primary potentially curative treatment for cancers of the blood and bone marrow. While relapse occurs in approximately 30% of patients, few risk-modifying genetic variants have been identified. The present study evaluates t...
Autores principales: | Ritari, J., Hyvärinen, K., Koskela, S., Itälä-Remes, M., Niittyvuopio, R., Nihtinen, A., Salmenniemi, U., Putkonen, M., Volin, L., Kwan, T., Pastinen, T., Partanen, J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6326954/ https://www.ncbi.nlm.nih.gov/pubmed/30089915 http://dx.doi.org/10.1038/s41375-018-0229-3 |
Ejemplares similares
-
Computational Analysis of HLA-presentation of Non-synonymous Recipient Mismatches Indicates Effect on the Risk of Chronic Graft-vs.-Host Disease After Allogeneic HSCT
por: Ritari, Jarmo, et al.
Publicado: (2019) -
Meta-Analysis of Genome-Wide Association and Gene Expression Studies Implicates Donor T Cell Function and Cytokine Pathways in Acute GvHD
por: Hyvärinen, Kati, et al.
Publicado: (2020) -
Clinically relevant germline variants in allogeneic hematopoietic stem cell transplant recipients
por: Lahtinen, Atte K., et al.
Publicado: (2022) -
Hidden genomic MHC disparity between HLA-matched sibling pairs in hematopoietic stem cell transplantation
por: Koskela, Satu, et al.
Publicado: (2018) -
Genetic polymorphism related to monocyte-macrophage function is associated with graft-versus-host disease
por: Hyvärinen, Kati, et al.
Publicado: (2017)